» Articles » PMID: 33677214

Migratory Cortical Interneuron-specific Transcriptome Abnormalities in Schizophrenia

Overview
Journal J Psychiatr Res
Specialty Psychiatry
Date 2021 Mar 7
PMID 33677214
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Cortical interneurons (cINs) are substantially affected in Schizophrenia (SCZ) and enriched for SCZ heritability during development. To understand SCZ-specific changes in these cells during development, we isolated migratory cINs from cIN spheres derived from 5 healthy control (HC) and 5 SCZ induced pluripotent stem cell lines (iPSCs). Transcriptome analyses show dysregulation in extracellular matrix pathways as the major disturbances in SCZ migratory cINs, whereas sphere cINs show dysregulation in immune pathways. This result suggests the importance of using homogeneous cell populations to identify stage-specific abnormalities and provides a platform to further study the biology of schizophrenia pathogenesis during early development.

Citing Articles

Peering into the mind: unraveling schizophrenia's secrets using models.

Nani J, Muotri A, Hayashi M Mol Psychiatry. 2024; 30(2):659-678.

PMID: 39245692 DOI: 10.1038/s41380-024-02728-w.


Harnessing stem cell-based approaches for clinically meaningful discoveries in schizophrenia.

Lizano P, Karmacharya R Schizophr Res. 2024; 273:1-3.

PMID: 39209607 PMC: 11570341. DOI: 10.1016/j.schres.2024.08.006.


Current advancements of modelling schizophrenia using patient-derived induced pluripotent stem cells.

Dubonyte U, Asenjo-Martinez A, Werge T, Lage K, Kirkeby A Acta Neuropathol Commun. 2022; 10(1):183.

PMID: 36527106 PMC: 9756764. DOI: 10.1186/s40478-022-01460-2.


Probing the molecular and cellular pathological mechanisms of schizophrenia using human induced pluripotent stem cell models.

Sebastian R, Song Y, Pak C Schizophr Res. 2022; 273:4-23.

PMID: 35835709 PMC: 9832179. DOI: 10.1016/j.schres.2022.06.028.


Making Sense of Patient-Derived iPSCs, Transdifferentiated Neurons, Olfactory Neuronal Cells, and Cerebral Organoids as Models for Psychiatric Disorders.

Unterholzner J, Millischer V, Wotawa C, Sawa A, Lanzenberger R Int J Neuropsychopharmacol. 2021; 24(10):759-775.

PMID: 34216465 PMC: 8538891. DOI: 10.1093/ijnp/pyab037.